Clinical trials
Terminated Phase 1/2 Sarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| City of Hope Medical Center | 2 |
| Dana-Farber Cancer Institute | 1 |
| Eli Lilly and Company | 1 |
| Gulam Manji | 1 |
| Hutchmed | 1 |
| Immodulon Therapeutics Ltd | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| NBE-Therapeutics AG | 1 |
| NantCell, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma | 22 |
| Neoplasm Metastasis | 7 |
| Carcinoma, Renal Cell | 4 |
| Colorectal Neoplasms | 4 |
| Melanoma | 4 |
| Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Triple Negative Breast Neoplasms | 4 |
| Carcinoma, Merkel Cell | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.